Literature DB >> 16132396

Percutaneous radiofrequency ablation for the treatment of liver neoplasms in the caudate lobe left of the vena cava: electrode placement through the left lobe of the liver under CT-fluoroscopic guidance.

Koichiro Yamakado1, Atsuhiro Nakatsuka, Masao Akeboshi, Haruyuki Takaki, Kan Takeda.   

Abstract

Five hepatocellular carcinomas and one liver metastasis located in the caudate lobe left of the inferior vena cava were successfully treated by radiofrequency (RF) ablation by placing the RF electrode into each tumor through the left lobe of the liver under the CT-fluoroscopic guidance. All tumors were free of enhancement on dynamic contrast-enhanced CT during the mean follow-up period of 6.3 months. There were no major complications related to the procedures.

Entities:  

Mesh:

Year:  2005        PMID: 16132396     DOI: 10.1007/s00270-004-0104-7

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  4 in total

Review 1.  Hepatocellular carcinoma in the caudate lobe of the liver: variations of its feeding branches on arteriography.

Authors:  Shiro Miyayama; Masashi Yamashiro; Yuichi Yoshie; Yoshiko Nakashima; Hiroshi Ikeno; Nobuaki Orito; Miki Yoshida; Osamu Matsui
Journal:  Jpn J Radiol       Date:  2010-10-24       Impact factor: 2.374

2.  Prognostic factors in the surgical treatment of caudate lobe hepatocellular carcinoma.

Authors:  Peng Liu; Jia-Mei Yang; Wen-Yang Niu; Tong Kan; Feng Xie; Dian-Qi Li; Ye Wang; Yan-Ming Zhou
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

3.  Precautions in caudate lobe resection: report of 11 cases.

Authors:  Zeng-Qing Wen; Yi-Qun Yan; Jia-Mei Yang; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

4.  Hydrochloric acid enhanced radiofrequency ablation for treatment of large hepatocellular carcinoma in the caudate lobe: Report of three cases.

Authors:  Han-Xia Deng; Jin-Hua Huang; Wan Yee Lau; Fei Ai; Min-Shan Chen; Zhi-Mei Huang; Tian-Qi Zhang; Meng-Xuan Zuo
Journal:  World J Clin Cases       Date:  2019-02-26       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.